Lundbeck gives up on Alzheimer's drug, rival to Axovant pill

(Reuters) - Two remaining late-stage clinical trials testing an experimental Alzheimer's drug from Denmark's Lundbeck have failed, scuppering hopes for the medicine and underscoring the difficulty of developing such treatments.